FARMINGDALE, N.Y., Aug. 1, 2011 /PRNewswire/ — Misonix, Inc.
(NASDAQ:
MSON), a medical device company that designs, manufactures and
markets innovative therapeutic ultrasonic products worldwide for
wound debridement, spinal surgery, cosmetic surgery, neurosurgery,
laparoscopic surgery, and other surgical and medical applications,
has entered into a new three-year exclusive distribution agreement
with Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma
will sell and distribute the SonaStar® Ultrasonic Surgical
Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter
throughout Chile. The agreement includes annual minimum purchase
requirements.
Osteotrauma has earned a reputation for introducing high tech,
state-of-the-art medical devices to the Chilean market and is
respected for their commitment to excellence in customer service.
Osteotrauma supplies a wide range of specialty medical products to
the Chilean market with a focus on neurosurgery and spine
surgery.
The SonaStar is used by Neuro and General Surgeons for quick and
efficient removal of both hard and soft tumors while sparing most
vessels. In addition, OsteoSculpt™ bone sculpting
technology can be employed with the SonaStar to safely remove
osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of
making precise cuts through bone and hard tissue while largely
preserving delicate soft tissue structures. It offers the
convenience and speed of a power instrument while minimizing the
peril associated with rotary sharps.
“Misonix is pleased to add Osteotrauma to our sales family as we
put the finishing touches on our Latin American distribution
network. Their reputation as a quality distributor of medical
equipment and devices in Chile is well established,” said Michael
A. McManus, Jr.
‘/>”/>
